Cargando…
MicroRNA-4530 promotes angiogenesis by targeting VASH1 in breast carcinoma cells
The results of our previous study revealed that microRNA (miRNA/miR)-4530 was upregulated in the serum of patients with diabetic retinopathy. The TargetScan miRNA database was used to identify potential targets of miR-4530 and vasohibin-1 (VASH1) was predicted as one of the targets. The results of o...
Autores principales: | Zhang, Tao, Jing, Li, Li, Hong, Ding, Linchao, Ai, Dongdong, Lyu, Jianxin, Zhong, Lianjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494889/ https://www.ncbi.nlm.nih.gov/pubmed/28693142 http://dx.doi.org/10.3892/ol.2017.6102 |
Ejemplares similares
-
MicroRNA-4530 suppresses cell proliferation and induces apoptosis by targeting RASA1 in human umbilical vein endothelial cells
por: Jing, Li, et al.
Publicado: (2019) -
Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by VEGF-Mediated EZH2/VASH1 Pathway
por: Huang, Bin, et al.
Publicado: (2019) -
MicroRNA-125a-3p, -4530, and -92a as a Potential Circulating MicroRNA Panel for Noninvasive Pancreatic Cancer Diagnosis
por: Seyed Salehi, Ali, et al.
Publicado: (2022) -
VASH1–SVBP and VASH2–SVBP generate different detyrosination profiles on microtubules
por: Ramirez-Rios, Sacnicte, et al.
Publicado: (2022) -
Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2
por: Wang, Xiao-Xiao, et al.
Publicado: (2018)